Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

JAK Inhibition Reduces CD25 high CD27 + FOXp3 + T Regulatory Cells and Causes a Silencing Of T Effector Cells In Patients With Myeloproliferative Neoplasms Whilst Promoting a TH17 Phenotype

Clodagh Keohane, MD, Shahram Y Kordasti, MD, PhD, Thomas Seidl, Pilar Perez Abellan, Nicholas Shaun B. Thomas, PhD, Ghulam J Mufti, FRCP, FRCPath, Claire N Harrison, DM, FRCP, FRCPath, Donal McLornan, MD, PhD

Blood (2013) 122 (21): 4092.

https://doi.org/10.1182/blood.V122.21.4092.4092

Published: 2013

Journal Articles

Chronic Relapsing Remitting Sweet’s Syndrome- a Harbinger Of Myelodysplastic Syndrome (MDS), Single Centre Analysis Of 31 Patients

Austin G Kulasekararaj, Shahram Y Kordasti, Tanya Basu, Jon Salisbury, Anthony du Vivier, Ghulam J. Mufti, MD, PhD

Blood (2013) 122 (21): 2793.

https://doi.org/10.1182/blood.V122.21.2793.2793

Published: 2013

Journal Articles

Characteristics and Outcome Of Myelodysplastic Syndromes (MDS) Patients With Autoimmune Diseases

Rami S Komrokji, MD, Austin G Kulasekararaj, MBBS, MD, MRCP, FRCP, Najla H Al Ali, Shahram Y Kordasti, MD, PhD, Emily Bart-smith, Craig Benjamin, Eric Padron, MD, Ling Zhang, MD, Jeffrey E Lancet, MD, Alan List, MD, Ghulam J Mufti, FRCP, FRCPath, M.D., Pearlie K Epling-Burnette, PhD

Blood (2013) 122 (21): 746.

https://doi.org/10.1182/blood.V122.21.746.746

Published: 2013

Journal Articles

Functional Characterization of CD4 + T-Cells in Aplastic Anemia (AA)

Shahram Y Kordasti, MD, PhD, Judith C. W. Marsh, Prof MD PhD, Sufyan Al-Khan, MD, Jie Jiang, PhD, Alexander E Smith, PhD, Azim M Mohamedali, PhD, Pilar Perez Abellan, Caroline Veen, Benedetta Costantini, MD, Nana Benson Quarm, Thomas Seidl, Syed A Mian, Farzin Farzaneh, DPhil, Ghulam J. Mufti, MD

Blood (2011) 118 (21): 1340.

https://doi.org/10.1182/blood.V118.21.1340.1340

Published: 2011

Journal Articles

5-Azacytidine Specifically Depletes Regulatory T Cells (Tregs) in Myelodysplastic Syndrome (MDS) Patients

Benedetta Costantini, MD, Shahram Y Kordasti, MD, PhD, Austin G Kulasekararaj, MBBS, MD, MRCP, FRCP, Jie Jiang, PhD, Thomas Seidl, Pilar Perez Abellan, Janet Hayden, Farzin Farzaneh, DPhil, Ghulam J. Mufti, MD

Blood (2011) 118 (21): 787.

https://doi.org/10.1182/blood.V118.21.787.787

Published: 2011

Journal Articles

CD80-IL2 Expressing Myeloma Cells for Immune Gene Therapy of Multiple Myeloma

Giulia Giunti, David Malone, Lucas Chan, Darling David, Shahram Y Kordasti, MD, PhD, Linda Barber, Oppenheim David, Farzin Farzaneh, DPhil, Stephen Schey

Blood (2011) 118 (21): 4718.

https://doi.org/10.1182/blood.V118.21.4718.4718

Published: 2011

Journal Articles

Contrasting Roles of Th1 and Th17 Cells in Aplastic Anaemia (AA) and Myelodysplastic Syndrome (MDS).

Shahram Y Kordasti, MD, Sufyan M AlKhan, Ziyi Lim, Pilar Perez Abellan, Judith C W Marsh, Ghulam J Mufti, MBBS, DM, FRCP, FRCPath

Blood (2009) 114 (22): 1090.

https://doi.org/10.1182/blood.V114.22.1090.1090

Published: 2009

Journal Articles

RFUSIN2 - a Clinical Grade Lentiviral Vector Co-Expressing CD80/IL-2 Manufactured Under GMP for a Phase I Clinical Trial Study of Immune Gene Therapy for Poor Prognosis Acute Myeloid Leukaemia

Lucas Chan, Wendy Ingram, Nicola Hardwick, David Darling, Joti Bhalla, Aytug Kizilors, Shahram Y Kordasti, Ghulam J Mufti, Farzin Farzaneh

Blood (2008) 112 (11): 4630.

https://doi.org/10.1182/blood.V112.11.4630.4630

Published: 2008

Journal Articles

Increased Number of IL-17 Producing CD4 + T Cells in Low Risk Myelodysplastic Syndrome (MDS)

Shahram Y Kordasti, Behdad Afzali, Ziyi Lim, Wendy Ingram, Janet Hayden, Linda Barber, Giovanna Lombardi, Farzin Farzaneh, Ghulam J Mufti, MBBS, DM, FRCP, FRCPath

Blood (2008) 112 (11): 637.

https://doi.org/10.1182/blood.V112.11.637.637

Published: 2008

Journal Articles

CD4 + CD25 high Foxp3 + Regulatory T-Cells Are Correlated with Different Risk Factors in Myelodysplastic Syndrome (MDS).

Shahram Y. Kordasti, MD, Wendy Ingram, MD, Janet Hayden, RCN, David Darling, PhD, Linda Barber, PhD, Farzin Farzaneh, PhD, Ghulam Mufti, MD

Blood (2007) 110 (11): 2445.

https://doi.org/10.1182/blood.V110.11.2445.2445

Published: 2007

Journal Articles

CD4 + CD25 high Foxp3 + regulatory T cells in myelodysplastic syndrome (MDS)

Shahram Y. Kordasti, Wendy Ingram, Janet Hayden, David Darling, Linda Barber, Behdad Afzali, Giovanna Lombardi, Marcin W. Wlodarski, Jaroslaw P. Maciejewski, Farzin Farzaneh, Ghulam J. Mufti

Blood (2007) 110 (3): 847–850.

https://doi.org/10.1182/blood-2007-01-067546

Published: 2007

Journal Articles

Expansion of Polyclonal CD4 + CD25 high Foxp3 + Regulatory T-Cells in High Risk Myelodysplastic Syndromes (MDS).

Shahram Y. Kordasti, MD, Wendy Ingram, MD, Janet Hayden, RN, David Darling, PhD, Linda Barber, PhD, Farzin Farzaneh, PhD, Ghulam J. Mufti, MD

Blood (2006) 108 (11): 2641.

https://doi.org/10.1182/blood.V108.11.2641.2641

Published: 2006

NARROW

JAK Inhibition Reduces CD25 high CD27 + FOXp3 + T Regulatory Cells and Causes a Silencing Of T Effector Cells In Patients With Myeloproliferative Neoplasms Whilst Promoting a TH17 Phenotype

Chronic Relapsing Remitting Sweet’s Syndrome- a Harbinger Of Myelodysplastic Syndrome (MDS), Single Centre Analysis Of 31 Patients

Characteristics and Outcome Of Myelodysplastic Syndromes (MDS) Patients With Autoimmune Diseases

Functional Characterization of CD4 + T-Cells in Aplastic Anemia (AA)

5-Azacytidine Specifically Depletes Regulatory T Cells (Tregs) in Myelodysplastic Syndrome (MDS) Patients

CD80-IL2 Expressing Myeloma Cells for Immune Gene Therapy of Multiple Myeloma

Contrasting Roles of Th1 and Th17 Cells in Aplastic Anaemia (AA) and Myelodysplastic Syndrome (MDS).

RFUSIN2 - a Clinical Grade Lentiviral Vector Co-Expressing CD80/IL-2 Manufactured Under GMP for a Phase I Clinical Trial Study of Immune Gene Therapy for Poor Prognosis Acute Myeloid Leukaemia

Increased Number of IL-17 Producing CD4 + T Cells in Low Risk Myelodysplastic Syndrome (MDS)

CD4 + CD25 high Foxp3 + Regulatory T-Cells Are Correlated with Different Risk Factors in Myelodysplastic Syndrome (MDS).

CD4 + CD25 high Foxp3 + regulatory T cells in myelodysplastic syndrome (MDS)

Expansion of Polyclonal CD4 + CD25 high Foxp3 + Regulatory T-Cells in High Risk Myelodysplastic Syndromes (MDS).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only